Vista Pharmaceuticals bulk deals, insider trading and stake changes
BSE: 524711Pharmaceuticals & BiotechnologySmall Cap
Last close ₹5.84up ₹0.36 (6.57%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹5.48.
52-week range of traded prices to 23 Oct 2026
₹5.32Low, 16 Sep 2026₹10.50High, 23 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹36 Cr3,508th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 1.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- −28.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- −32.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.27
- Volume, BSEVolume. Shares traded on the last trading day.
- 6,933
Vista Pharmaceuticals insider trading
All 25 disclosures on record. The company's own latest disclosure on record is from Aug 2021.Insider trading, all companies
Jul 2021
- Dhananjaya Alli₹0.20 Cr10,07,391 sharesReceived · KMP · 26 Jul 2021 · disclosed 2 Aug · Gift · stake 7.69% before, 10.43% after
Mar 2021
- Dhananjaya Alli₹0.28 Cr14,00,000 sharesReceived · KMP · 19 Mar 2021 · disclosed 22 Mar · Gift · stake 3.89% before, 7.69% after
Aug 2020
- Anand Chittajallu₹0.29 Cr14,28,570 sharesReceived · Director · 3 Aug 2020 · disclosed 5 Aug · Allotment · held none before, holds 14,28,570 after
- Umakanth Katta₹0.57 Cr28,57,144 sharesReceived · Director · 3 Aug 2020 · disclosed 5 Aug · Allotment · held 21,42,856 before, holds 50,00,000 after
Jul 2020
- Umakanth Katta₹0.21 Cr10,71,428 sharesReceived · Director · 13 Jul 2020 · disclosed 14 Jul · Allotment · held 10,71,428 before, holds 21,42,856 after, stake 6.59% after
Feb 2019
- Vasant V Alli₹0.71 Cr1,90,574 sharesReceived · Promoter · 6 Feb 2019 · disclosed 8 Feb · Conv. of Warrants · stake 4.68% before, 5.27% after
- Vasant V Alli₹0.71 Cr1,90,574 unitsGave · Promoter · 6 Feb 2019 · Convertible Warrants · disclosed 8 Feb · Conv. of Warrants · held 4,72,429 before, holds 2,81,855 after
Jan 2019
- Vasant V Alli₹0.71 Cr1,89,851 sharesReceived · Promoter · 24 Jan 2019 · Conv. of Warrants · stake 4.07% before, 4.68% after
- Vasant V Alli₹0.71 Cr1,89,851 unitsGave · Promoter · 24 Jan 2019 · Convertible Warrants · Conv. of Warrants · held 6,62,280 before, holds 4,72,429 after
Earlier, Mar 2017 to Dec 2018Hide earlier
Dec 2018
- Vasant V Alli Revised₹3.14 Cr8,37,720 unitsGave · Promoter · 26 Dec 2018 · Convertible Warrants · disclosed 28 Dec · Pref. Allotment · held 15,00,000 before, holds 6,62,280 after
- Vasant V Alli Revised₹3.14 Cr8,37,720 sharesReceived · Promoter · 26 Dec 2018 · disclosed 28 Dec · Pref. Allotment · held 3,83,333 before, holds 12,21,053 after, stake 4.07% after
Nov 2017
- Vasant V Alli₹1.88 Cr15,00,000 unitsReceived · Promoter · 28 Nov 2017 · Convertible Warrants · disclosed 29 Nov · Pref. Allotment · holds 15,00,000 after
Jul 2017
- Dhananjaya Alli₹1.23 Cr5,11,561 unitsGave · Promoter & Director · 28 Jul 2017 · Convertible Warrants · Conv. of Warrants · held 22,81,561 before, holds 17,70,000 after
- Dhananjaya Alli₹1.23 Cr5,11,561 sharesReceived · Promoter & Director · 28 Jul 2017 · Conv. of Warrants · held 9,18,472 before, holds 14,30,033 after, stake 4.99% after
- Vista Pharmaceuticals Inc₹0.51 Cr2,11,000 sharesReceived · Promoter · 28 Jul 2017 · Conv. of Warrants · held 63,68,620 before, holds 65,79,620 after, stake 22.97% after
- Vista Pharmaceuticals Inc₹0.51 Cr2,11,000 unitsGave · Promoter · 28 Jul 2017 · Convertible Warrants · Conv. of Warrants · held 10,43,808 before, holds 8,32,808 after
- Dhananjaya Alli Revised₹1.85 Cr7,68,439 sharesReceived · Promoter & Director · 7 Jul 2017 · disclosed 8 Jul · Conv. of Warrants · held 1,50,033 before, holds 9,18,472 after
- Vista Pharmaceuticals Inc Revised₹0.86 Cr3,56,192 unitsGave · Promoter · 7 Jul 2017 · Convertible Warrants · disclosed 8 Jul · Conv. of Warrants · held 14,00,000 before, holds 10,43,808 after
- Vista Pharmaceuticals Inc Revised₹0.86 Cr3,56,192 sharesReceived · Promoter · 7 Jul 2017 · disclosed 8 Jul · Conv. of Warrants · held 60,12,428 before, holds 63,68,620 after
- Dhananjaya Alli Revised₹1.85 Cr7,68,439 unitsGave · Promoter & Director · 7 Jul 2017 · Convertible Warrants · disclosed 8 Jul · Conv. of Warrants · held 30,50,000 before, holds 22,81,561 after
Apr 2017
- Dhananjaya Alli30,50,000unitsOther · Promoter & Director · 13 Apr 2017 · Warrants · disclosed 15 Apr · Pref. Allotment · holds 30,50,000 after
- Dhananjaya Alli₹0.36 Cr1,50,000 sharesReceived · Promoter & Director · 13 Apr 2017 · disclosed 15 Apr · Pref. Allotment · held 33 before, holds 1,50,033 after, stake 0.56% after
- Vista Pharmaceuticals Inc₹0.19 Cr78,714 sharesReceived · Promoter · 13 Apr 2017 · disclosed 15 Apr · Pref. Allotment · stake 22.33% before, 22.43% after
- Vista Pharmaceuticals Inc14,00,000unitsOther · Promoter · 13 Apr 2017 · Warrants · disclosed 15 Apr · Pref. Allotment · holds 14,00,000 after
Mar 2017
- Vista Pharmaceuticals Inc₹3.78 Cr15,71,286 sharesReceived · Promoter · 31 Mar 2017 · disclosed 1 Apr · Pref. Allotment · held 43,62,428 before, holds 59,33,714 after, stake 22.33% after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Vista Pharmaceuticals stake sales and purchases
All 24 disclosures on record.
Dec 2022
- AcquiredKamal Gadalay & PACs0.14% of the company52,625 sharesholds 4.52% after21 Dec 2022 · filed under the 2% rule · Market
- AcquiredSuresh Gadaley & PACs0.13% of the company50,000 sharesholds 11.69% after21 Dec 2022 · filed under the 5% rule · Market
Jul 2021
- SoldBojja Sreenivasulu2.74% of the company10,07,391 shares26 Jul 2021 · filed under the 2% rule · Market
- AcquiredDhananjaya Alli · promoter2.74% of the company10,07,391 sharesholds 10.43% after26 Jul 2021 · filed under the 2% rule · Market
Mar 2021
- SoldBojja Sreenivasulu3.80% of the company14,00,000 sharesholds 2.74% after19 Mar 2021 · filed under the 2% rule · Market
- AcquiredDhananjay Alli · promoter3.80% of the company14,00,000 sharesholds 7.69% after19 Mar 2021 · filed under the 2% rule · Market
Aug 2020
- AcquiredAnand Chittajallu3.88% of the company14,28,570 sharesholds 3.88% after3 Aug 2020 · filed under the 5% rule · Preferential allotment
- AcquiredUmakanth Katta7.76% of the company28,57,144 sharesholds 13.58% after3 Aug 2020 · filed under the 5% rule · Preferential allotment
Jul 2020
- AcquiredUmakanth Katta3.29% of the company10,71,428 sharesholds 6.59% after13 Jul 2020 · filed under the 5% rule · Preferential allotment
- AcquiredUmakanthKatta3.40% of the company10,71,428 sharesholds 3.40% after7 Jul 2020 · filed under the 5% rule · Preferential allotment
Feb 2019
- AcquiredVasant V Alli · promoter0.63% of the company1,90,574 sharesholds 5.27% after6 Feb 2019 · filed under the 5% rule · Preferential allotment
Earlier, Mar 2017 to Jan 2019Hide earlier
Jan 2019
- AcquiredVasant V Alli · promoter0.63% of the company1,89,851 sharesholds 4.68% after24 Jan 2019 · filed under the 5% rule · Preferential allotment
Dec 2018
- AcquiredVasant V Alli · promoter2.79% of the company8,37,720 sharesholds 4.07% after26 Dec 2018 · filed under the 5% rule · Preferential allotment
Sep 2017
- SoldKeshava Murthy Shiva Shankar3.14% of the company9,00,500 sharesholds 5.95% after14 Sep 2017 · filed under the 2% rule · Market
Jul 2017
- AcquiredVista Pharmaceuticals Inc · promoter0.74% of the company2,11,000 sharesholds 22.97% after28 Jul 2017 · filed under the 2% rule · Preferential allotment
- AcquiredDhananjaya Alli · promoter1.79% of the company5,11,561 sharesholds 4.99% after19 Jul 2017 · filed under the 5% rule · Preferential allotment
- AcquiredDhananjaya Alli · promoter2.75% of the company7,68,439 sharesholds 3.29% after7 Jul 2017 · filed under the 5% rule · Preferential allotment
- AcquiredVista Pharmaceuticals Inc · promoter1.28% of the company3,56,192 sharesholds 22.81% after7 Jul 2017 · filed under the 2% rule · Preferential allotment
Apr 2017
- AcquiredDhananjaya Alli · promoter0.56% of the company1,50,000 sharesholds 0.56% after13 Apr 2017 · filed under the 5% rule · Preferential allotment
- AcquiredVista Pharmaceuticals Inc · promoter0.29% of the company78,714 sharesholds 22.43% after13 Apr 2017 · filed under the 2% rule · Preferential allotment
Mar 2017
- AcquiredVista Pharmaceuticals Inc · promoter5.91% of the company15,71,286 sharesholds 22.33% after31 Mar 2017 · filed under the 2% rule · Preferential allotment
- SoldGopal Dasari10.69% of the company26,71,666 shares3 Mar 2017 · filed under the 2% rule · Off Market
- AcquiredPradeep Kumar Samala10.69% of the company26,71,666 sharesholds 10.69% after3 Mar 2017 · filed under the 5% rule · Off Market
- SoldPradeep Kumar Samala7.60% of the company19,00,000 sharesholds 3.09% after3 Mar 2017 · filed under the 2% rule · Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Vista Pharmaceuticals bulk deals
None in the last 12 months, since 23 Oct 2025.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Wednesday 12 Jun 20241 firm · ₹0 bought · ₹0.35 Cr soldNet sold ₹0.35 Cr
- SoldUMAKANTH KATTASold 2,61,188 at ₹13.540.56% of the company₹0.35 Cr
Monday 10 Jun 20242 firms · ₹0.66 Cr bought · ₹1.00 Cr soldNet sold ₹0.34 Cr
- SoldUMAKANTH KATTASold 7,50,979 at ₹13.331.60% of the company₹1.00 Cr
- BoughtSUNDARA RAO BEHTABought 5,00,000 at ₹13.291.07% of the company₹0.66 Cr
Wednesday 5 Jun 20242 firms · ₹0.40 Cr bought · ₹0.40 Cr soldNet nil
- SoldUMAKANTH KATTASold 3,00,103 at ₹13.220.64% of the company₹0.40 Cr
- BoughtMEHJABEEN SHALAMBought 3,00,000 at ₹13.220.64% of the company₹0.40 Cr
Wednesday 28 Dec 20221 firm · ₹0.26 Cr bought · ₹0.35 Cr soldNet sold ₹0.10 Cr
- Both waysMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDBought 1,83,682 at ₹13.93Sold 2,44,668 at ₹14.410.66% of the companyNet −60,986 shares₹0.26 Cr bought
Monday 18 Apr 20221 firm · ₹0 bought · ₹0.17 Cr soldNet sold ₹0.17 Cr
- SoldNAVEEN MALVAYSold 2,01,528 at ₹8.430.55% of the company₹0.17 Cr
Wednesday 29 Dec 20211 firm · ₹0.25 Cr bought · ₹0 soldNet bought ₹0.25 Cr
- BoughtSURESH GADALEYBought 2,63,734 at ₹9.330.72% of the company₹0.25 Cr
Friday 13 Sep 20192 firms · ₹0.23 Cr bought · ₹0.22 Cr soldNet bought ₹80,897
- BoughtNAVEEN MALVAYBought 2,00,000 at ₹11.300.66% of the company₹0.23 Cr
- SoldUMESH CHAMDIASold 1,92,841 at ₹11.300.64% of the company₹0.22 Cr
Tuesday 27 Aug 20192 firms · ₹0.33 Cr bought · ₹0.22 Cr soldNet bought ₹0.11 Cr
- BoughtAPARNA SAMIR THAKKERBought 4,06,129 at ₹8.151.34% of the company₹0.33 Cr
- SoldYASH JASBIR OBEROISold 2,73,721 at ₹8.150.90% of the company₹0.22 Cr
Friday 29 Mar 20192 firms · ₹0.72 Cr bought · ₹0.73 Cr soldNet sold ₹65,085
- SoldMANJU PURUSHOTTAM CHAMDIASold 3,60,000 at ₹20.151.20% of the company₹0.73 Cr
- BoughtUMESH CHAMDIABought 3,56,770 at ₹20.151.19% of the company₹0.72 Cr
Wednesday 26 Sep 20182 firms · ₹1.21 Cr bought · ₹1.21 Cr soldNet nil
- SoldAPARNA SAMIR THAKKERSold 4,05,000 at ₹29.921.39% of the company₹1.21 Cr
- BoughtASAWARI VITTAL OTAWKARBought 4,05,000 at ₹29.921.39% of the company₹1.21 Cr
Friday 22 Jun 20182 firms · ₹1.27 Cr bought · ₹1.27 Cr soldNet nil
- BoughtAPARNA SAMIR THAKKERBought 3,20,000 at ₹39.601.10% of the company₹1.27 Cr
- SoldASAWARI VITTAL OTAWKARSold 3,20,000 at ₹39.601.10% of the company₹1.27 Cr
Thursday 21 Jun 20182 firms · ₹1.19 Cr bought · ₹1.19 Cr soldNet nil
- SoldAPARNA SAMIR THAKKERSold 3,20,000 at ₹37.131.10% of the company₹1.19 Cr
- BoughtASAWARI VITTAL OTAWKARBought 3,20,000 at ₹37.131.10% of the company₹1.19 Cr
Thursday 1 Mar 20182 firms · ₹1.06 Cr bought · ₹2.40 Cr soldNet sold ₹1.35 Cr
- SoldKESHAVA MURTHY SHIVASHANKARSold 4,50,000 at ₹51.021.57% of the company₹2.30 Cr
- Both waysBP FINTRADE PRIVATE LIMITEDBought 2,07,344 at ₹51.04Sold 21,048 at ₹51.310.72% of the companyNet +1,86,296 shares₹1.06 Cr bought
Wednesday 28 Feb 20181 firm · ₹1.79 Cr bought · ₹0 soldNet bought ₹1.79 Cr
- BoughtAPARNA SAMIR THAKKERBought 3,40,000 at ₹52.551.19% of the company₹1.79 Cr
Wednesday 13 Sep 20171 firm · ₹0 bought · ₹4.01 Cr soldNet sold ₹4.01 Cr
- SoldKESHAVA MURTHY SHIVASHANKARSold 9,00,500 at ₹44.513.14% of the company₹4.01 Cr
Wednesday 16 Aug 20171 firm · ₹0 bought · ₹0.41 Cr soldNet sold ₹0.41 Cr
- SoldKARTHIKEYAN RSold 1,59,178 at ₹25.700.56% of the company₹0.41 Cr
Friday 31 Mar 20171 firm · ₹0 bought · ₹1.95 Cr soldNet sold ₹1.95 Cr
- SoldPRADEEP KUMAR SAMALASold 5,52,749 at ₹35.252.21% of the company₹1.95 Cr
Friday 3 Mar 20174 firms · ₹1.55 Cr bought · ₹4.95 Cr soldNet sold ₹3.40 Cr
- SoldPRADEEP KUMAR SAMALASold 19,00,000 at ₹26.037.60% of the company₹4.95 Cr
- BoughtLALA MEHTAB SHAIKHBought 2,00,000 at ₹26.000.80% of the company₹0.52 Cr
- BoughtSACHIN KESHORE MEHTABought 2,00,000 at ₹25.770.80% of the company₹0.52 Cr
- BoughtSACHIN K MEHTA HUFBought 2,00,000 at ₹25.650.80% of the company₹0.51 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 29 deals on record from 4 Jan 2004.